-
Exelon CEO changes: Innocenzo departs 2027; Jones, Kleczynski, Levin, Plenge shift roles
Mike Innocenzo to leave as EVP & COO of Exelon, President/CEO of PECO, and ComEd Board Chair in 2027.
-
Exelon Reports First Quarter 2026 Adjusted Earnings of $0.91 Per Share, Affirms Full-Year Guidance
GAAP net income of $0.90 per share and adjusted operating earnings of $0.91 per share for Q1 2026.
-
Exelon shareholders elect all 9 director nominees, ratify auditor, approve say-on-pay
All nine director nominees elected with 92.8% to 99.3% of votes cast, broker non-votes excluded.
-
Exelon subsidiary PECO withdraws rate case filings; Maryland utility regulation changes
PECO withdrew electric and gas rate filings with PA PUC, citing customer affordability; delays grid modernization investments.
-
Exelon issues $775M of 4.950% Notes due 2036 to refinance maturing 3.400% Notes
Issued $775M in 4.950% Notes due March 15, 2036; interest payable semi-annually.
-
Exelon Q4 adj EPS $0.59 vs $0.64 YoY; FY25 $2.77; FY26 guide $2.81-$2.91
Q4 2025 GAAP EPS $0.58, adj EPS $0.59; full-year adj EPS $2.77 ($2.50 YoY).
-
Exelon assigns David DeWalt to two board committees, effective April 27, 2026
David DeWalt appointed to Talent Management and Compensation Committee.
-
Exelon closes $1B of 3.25% convertible notes due 2029; net proceeds ~$987.5M
Issued $1B aggregate principal (incl. $100M over-allotment) of 3.25% convertible senior notes due March 15, 2029.
-
Exelon EVP Glockner to depart Jan 1, 2026; duties split between CFO and CLS
David Glockner, EVP Compliance, Audit and Risk, departs effective Jan 1, 2026; receives severance per existing plan.
-
Exelon derivative settlement gets preliminary court approval; $40M insurance payout, governance reforms
Preliminary approval granted Nov 18, 2025 for consolidated derivative settlement related to ComEd bribery scheme.
-
Exelon announces ESP blackout period from Dec 3 to Dec 22, 2025
Blackout due to vendor change for Employee Savings Plan; starts Dec 3, 2025 at 4pm ET, ends week of Dec 22, 2025.
-
Exelon Q3 adjusted EPS $0.86, up from $0.71; reaffirms FY2025 guidance $2.64-$2.74
GAAP EPS $0.86, adjusted EPS $0.86 in Q3 2025 vs. $0.70/$0.71 year ago; net income $875M, up $168M.
-
Exelon Q2 adjusted EPS $0.39, down from $0.47 YoY; reaffirms FY guidance $2.64-2.74
GAAP net income $391M ($0.39/diluted) vs $448M ($0.45) in Q2 2024; adjusted operating earnings $392M ($0.39) vs $472M ($0.47).
-
Exelon shareholders elect all 9 director nominees, ratify PwC, approve say-on-pay
All nine director nominees elected with support ranging from 94.4% (Linda Jojo) to 99.7% (David DeWalt).
-
Exelon establishes $2.5B at-the-market equity offering program
May sell up to $2.5B aggregate gross sales price of common stock via sales agents and forward sellers.
-
Exelon Q1 adjusted EPS $0.92, reaffirms FY2025 guidance $2.64-$2.74
GAAP EPS $0.90, adjusted EPS $0.92 for Q1 2025, up from $0.66 and $0.68 YoY.
-
Exelon appoints David DeWalt to board of directors
David DeWalt appointed independent director effective March 10, 2025.
-
Exelon issues $1.0B in notes to repay $464M commercial paper; rates 5.125% (2031) and 5.875% (2055)
Issued $500M 5.125% notes due 2031 and $500M 5.875% notes due 2055.
-
Exelon closes $1B offering of 6.500% junior subordinated notes due 2055
Closed public offering of $1,000,000,000 aggregate principal of 6.500% Fixed-to-Fixed Reset Rate Junior Subordinated Notes due 2055.
-
Exelon Q4 adjusted EPS $0.64; initiates 2025 guidance $2.64-$2.74; raises 4-yr capex to $38B
Q4 2024 GAAP net income $0.64 per share; adjusted (non-GAAP) $0.64 per share, up from $0.60 in Q4 2023.
-
Exelon announces departure of Chief Legal Officer; Colette Honorable appointed successor
Gayle Littleton departs as EVP, Chief Legal Officer effective Jan 1, 2025; stays as Senior Advisor to CEO until Mar 31, 2025.
-
Exelon Q3 2024 adj EPS $0.71 vs $0.67; reaffirms FY2024 guidance $2.40-$2.50
GAAP net income $0.70/sh; adjusted operating EPS $0.71 (up from $0.67); FY2024 guidance reaffirmed at $2.40-$2.50; 5-7% EPS growth target through 2027 reaffirmed.
-
Exelon and subsidiaries enter $4.0B in amended revolving credit facilities
Exelon Corp. entered $900M five-year revolver with JPMorgan Chase Bank as administrative agent.
-
Exelon Q2 adjusted EPS $0.47 beats prior year; reaffirms FY2024 outlook
GAAP EPS $0.45; adjusted EPS $0.47 vs $0.41 in Q2 2023.
-
Exelon shareholders elect all 9 directors, approve charter amendment for 25% special meeting threshold
All director nominees elected with 94-99% for; John Young lowest at 94.28%.
-
Exelon Q1 adjusted EPS $0.68 vs $0.70 YoY; reaffirms FY guidance $2.40-$2.50
GAAP EPS $0.66 vs $0.67 Q1 2023; adjusted $0.68 vs $0.70; reaffirms full-year $2.40-$2.50 range.
-
Exelon appoints Bryan Segedi to Audit and Risk Committee effective April 30
Bryan Segedi assigned to Exelon's Audit and Risk Committee, effective April 30, 2024.
-
Exelon issues $1.7B in notes; repays $500M term loan and $689M commercial paper
$1.7B aggregate: $650M 5.150% notes due 2029, $650M 5.450% notes due 2034, $400M 5.600% notes due 2053.
-
Exelon Q4 adjusted EPS $0.60 vs $0.43 YoY; 2024 guidance $2.40-$2.50; dividend raised 5.6%
Q4 adjusted EPS $0.60 (GAAP $0.62) from $0.43 prior year; full-year 2023 adjusted EPS $2.38 (GAAP $2.34).
-
Exelon promotes Mike Innocenzo to COO; Dave Velazquez to lead PECO; CHRO succession
Mike Innocenzo becomes Exelon EVP & COO effective April 1, 2024; base salary $685k, LTI target $1.765M.
-
ComEd gets ~$450M 2024 rate hike vs $968M requested; BGE rates cut; Exelon reaffirms EPS guidance
ICC order grants ComEd ~$450M 2024 rate increase versus $968M requested; ROE set at 8.905% vs requested 10.50-10.65%.
-
Exelon assigns new directors Lillie, Rogers, Richo to board committees
Charisse Lillie appointed to Talent Management and Compensation Committee effective Dec 5, 2023.
-
Exelon elects former EY deputy global vice chair Bryan Segedi to board
Board expanded to ten members; Segedi elected effective January 1, 2024.
-
Exelon reports Q3 adjusted EPS $0.67, down from $0.75 YoY; narrows FY guidance to $2.32-$2.40
GAAP EPS $0.70; adjusted (non-GAAP) EPS $0.67, vs $0.75 a year ago.
-
Exelon and ComEd settle SEC investigation; agree to $46.2M penalty
Settlement with SEC resolves investigation related to 2020 deferred prosecution agreement conduct.
-
Exelon Q2 GAAP EPS $0.34, adj $0.41; reaffirms FY23 $2.30-$2.42
GAAP EPS from continuing ops $0.34 vs $0.47 YoY; adjusted operating EPS $0.41 vs $0.44.
-
Exelon elects Anna Richo to board of directors, effective August 1, 2023
Board size increased to nine; Richo will serve until the 2024 annual meeting.
-
Exelon reaches $40M derivative settlement over ComEd bribery allegations; court approval pending
Settlement includes $40M payment from insurers to Exelon; $10M allocated for plaintiffs' attorneys' fees.
-
Exelon CFO departure; internal successor named with $500K salary
Joseph R. Trpik Jr., SVP & Corporate Controller, departs June 29, 2023 for external opportunity.
-
Exelon posts summer 2023 investor presentation; content not disclosed in filing
Exelon furnished a summer 2023 investor presentation as Exhibit 99.1.
-
Exelon Q1 adjusted EPS $0.70 beats prior year $0.64; reaffirms FY guidance
GAAP EPS $0.67; adjusted (non-GAAP) operating EPS $0.70, up from $0.64 YoY.
-
Exelon shareholders elect all 8 director nominees, ratify PwC, approve say-on-pay and annual advisory vote
All 8 director nominees elected; Anthony Anderson received 768.1M FOR, 36.2M AGAINST, 1.4M ABSTAIN.
-
Exelon issues $2.5B in notes across three tranches to refinance debt
Issued $1B 5.150% notes due 2028, $850M 5.300% notes due 2033, $650M 5.600% notes due 2053.
-
Exelon posts Winter 2023 investor presentation; no material new data disclosed
Exelon furnished an investor presentation for Winter 2023 investor meetings on Feb 17, 2023.
-
Exelon announces three directors leaving, nominates two new board members
Paul Joskow retiring at April 25, 2023 annual meeting; Ann Berzin and Carlos Gutierrez not seeking reelection.
-
Exelon Q4 adj EPS $0.43, up from $0.39 YoY; guides 2023 $2.30-$2.42; dividend raised 6.7%
Q4 2022 GAAP EPS $0.43, adjusted EPS $0.43; full-year adjusted EPS $2.27 vs $1.83 in 2021.
-
ComEd expected to get new Chicago franchise; $90M equity fund proposed
New franchise license would have initial 15-year term ending Dec 31, 2037, with 5-year extension option.
-
ComEd files 2024-2027 rate plan with ICC; seeks $3.8-4.4B annual revenue
Proposed base rate revenue: $3.76B (2024), $3.93B (2025), $4.15B (2026), $4.35B (2027).
-
Exelon extends exchange offer for $2.0B unregistered notes to Jan 6, 2023
Exchange offers for $2.0B aggregate principal amount of unregistered notes extended to Jan 6, 2023.
-
Exelon sets CEO Calvin Butler's compensation: $1.25M base, $8M LTI target
Annual base salary of $1,250,000; AIP target 140% of base salary.